Expression profiling and pharmacogenomics of muscle and muscle disease
- 作者Eric P Hoffman; Debra C DuBois; Ruth I Hoffman; Richard R Almon
- 卷第3卷
- 期第3期
- 印刷ISSN1471-4892
- 文件大小157.27KB
- 发表时间2003
- DOI10.1016/s1471-4892(03)00041-9
Biology of Platelet Purinergic Receptors and Implications for Platelet HeterogeneityKoupenova, Milka; Ravid, Katya · Frontiers in Pharmacology · 2018
Pharmacochemistry of the platelet purinergic receptorsKenneth A. Jacobson; Francesca Deflorian; Shilpi Mishra; Stefano Costanzi · 2011
Role of purinergic receptors in platelet-nanoparticle interactionsDeb, Suryyani; Chatterjee, Mohor; Bhattacharya, Jaydeep; Lahiri, Prabir; Chaudhuri, Utpal; Choudhuri, Sankar Pal; Kar, Soumitra; Siwach, Om Parkash; Sen, Prasenjit; Dasgupta, Anjan. KR. · Nanotoxicology · 2007
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor FunctionMundell, S. J. · Molecular Pharmacology · 2006
Modeling Membrane Protein–Ligand Binding Interactions: The Human Purinergic Platelet ReceptorGreene, D'Artagnan; Botello-Smith, Wesley M.; Follmer, Alec; Xiao, Li; Lambros, Eleftherios; Luo, Ray · The Journal of Physical Chemistry B · 2016
Purinergic P2Y12 Receptor Blockade Inhibits Shear-Induced Platelet Phosphatidylinositol 3-Kinase ActivationResendiz, J. C. · Molecular Pharmacology · 2003
Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y <sub/>1</sub> receptor <i>in vitro</i>Maayani, Saul; Schwarz, Todd E.; Patel, Nayana D.; Craddock-Royal, Barbara D.; Tagliente, Thomas M. · Platelets · 2003